心血管疾病中的肠道微生物群:从生物标志物和潜在目标到个性化干预

Q4 Pharmacology, Toxicology and Pharmaceutics Current Pharmacogenomics and Personalized Medicine Pub Date : 2018-03-31 DOI:10.2174/1875692116666180511170329

Yaroslav I. Ashikhmin, A. Syrkin, A. Zamyatnin, Yong Zhang, P. Kopylov

{"title":"心血管疾病中的肠道微生物群:从生物标志物和潜在目标到个性化干预","authors":"Yaroslav I. Ashikhmin, A. Syrkin, A. Zamyatnin, Yong Zhang, P. Kopylov","doi":"10.2174/1875692116666180511170329","DOIUrl":null,"url":null,"abstract":"Ilyinsky Hospital, 143421, Moscow Region, Russia; Preventive and Urgent Cardiology Department, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Lomonosov Moscow State University, Belozersky Institute of Physico-Chemical Biology, Moscow, 119992, Russia; Institute of Personalized Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Department of Pharmacology, Harbin Medical University, Harbin, China","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions\",\"authors\":\"Yaroslav I. Ashikhmin, A. Syrkin, A. Zamyatnin, Yong Zhang, P. Kopylov\",\"doi\":\"10.2174/1875692116666180511170329\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ilyinsky Hospital, 143421, Moscow Region, Russia; Preventive and Urgent Cardiology Department, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Lomonosov Moscow State University, Belozersky Institute of Physico-Chemical Biology, Moscow, 119992, Russia; Institute of Personalized Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Department of Pharmacology, Harbin Medical University, Harbin, China\",\"PeriodicalId\":11056,\"journal\":{\"name\":\"Current Pharmacogenomics and Personalized Medicine\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Pharmacogenomics and Personalized Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1875692116666180511170329\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692116666180511170329","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 3

摘要

俄罗斯莫斯科地区伊林斯基医院，143421;莫斯科谢切诺夫第一医科大学预防和急诊心内科，119991，俄罗斯莫斯科;谢切诺夫第一莫斯科国立医科大学分子医学研究所，119991，俄罗斯莫斯科;莫斯科国立罗蒙诺索夫大学别洛泽斯基理化生物研究所，莫斯科，119992;谢切诺夫第一莫斯科国立医科大学个性化医学研究所，119991，俄罗斯莫斯科;哈尔滨医科大学药学系，中国哈尔滨

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The Gut Microbiota in Cardiovascular Diseases: From Biomarkers and Potential Targets to Personalized Interventions

Ilyinsky Hospital, 143421, Moscow Region, Russia; Preventive and Urgent Cardiology Department, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Lomonosov Moscow State University, Belozersky Institute of Physico-Chemical Biology, Moscow, 119992, Russia; Institute of Personalized Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia; Department of Pharmacology, Harbin Medical University, Harbin, China

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.